TY  - JOUR
T1  - Pharmacotherapy for adolescent obesity: A weighty issue
AU  - Joffe A
Y1  - 2005/06/15
N1  - 10.1001/jama.293.23.2932
JO  - JAMA
SP  - 2932
EP  - 2934
VL  - 293
IS  - 23
N2  - 
Until public health efforts to prevent child and adolescent obesity
are developed and successfully implemented on a broad scale, physicians are
likely to encounter significant numbers of obese adolescents for the foreseeable
future. Many of these young people display features associated with the development
of type 2 diabetes and cardiovascular disease, and some experience social
stigma and other psychosocial morbidity. Research has shown that obese adolescents
are likely to become obese adults,1 yet changing
the trajectory of obesity in this age group remains an elusive goal. Hence,
appropriate management of this chronic health condition is a pressing but
daunting task for physicians.

SN  - 0098-7484
M3  - doi: 10.1001/jama.293.23.2932
UR  - http://dx.doi.org/10.1001/jama.293.23.2932
ER  -